Guest Editors Klaus F. Rabe Klaus F. Rabe is Professor of Pulmonary Medicine at the University of Kiel (Kiel, Germany) and Director of the Department of Pneumology at Lung Clinic Grosshansdorf (Grosshansdorf, Germany). He has been active in various fields of respiratory medicine worldwide, predominantly asthma, COPD and lung cancer. Professor Rabe took his final exams in medicine at the University of Hamburg (Hamburg, Germany) in 1983 and his clinical education began at Marienkrankenhaus Hamburg (1983–1987) where he then spent time working at Universitatskrankenhaus ¨ Eppendorf (University of Hamburg) within the intensive care and endoscopic units. In 1988, Professor Rabe worked in the pulmonary division of Krankenhaus Grosshansdorf, the Centre for Pneumology and Thoracic Surgery (Grosshandsdorf), and then in 1989, he worked in clinical research in the Department of Thoracic Medicine of the National Heart and Lung Institute (London, UK). In 1998, Professor Rabe was nominated Professor of Medicine at the University of Leiden (Leiden, the Netherlands) where he was also appointed as the Chairman of Pulmonology, and later, in 2007, as the Chairman of Medicine. In 2010, he moved back to Germany into his current position. Professor Rabe has served on various editorial boards, was the first European Associate Editor of the American Journal of Respiratory and Critical Care Medicine and was co-Chief Editor of the European Respiratory Journal. His current scientific interests are related to large clinical trials in COPD and asthma, the mechanisms of airway inflammation, and the endoscopic staging of lung cancer. Professor Rabe has served on the boards of the Global Initiative for Asthma (GINA) and the Global Initiative of Chronic Obstructive Lung Disease (GOLD), and is a member of the German and Dutch Chest Societies, the British Pharmacological Society, and the American Thoracic Society (ATS). He is the immediate Past-President of the European Respiratory Society (ERS). Jadwiga A. Wedzicha Jadwiga A. Wedzicha is Professor of Respiratory Medicine at the UCL Medical School and the Royal Free Hospital (both London, UK). She qualified from Somerville College (Oxford University, Oxford, UK) and St Bartholomew’s Hospital Medical College (University of London, London). Professor Wedzicha has a major interest in the causes, mechanisms, impact and prevention of COPD exacerbations and in the role of bacterial and viral infection in COPD exacerbation. She directs an active research group into COPD exacerbations and has published extensively on this topic. Professor Wedzicha chairs the English Department of Health Home Oxygen Clinical User Group, and was a member of the Guideline Development Group for the revision of the NICE COPD Guidelines. She is also a member of the Programme Board for the English COPD National Clinical Strategy. Professor Wedzicha was Editor-in-Chief of Thorax from 2002 to 2010, and is a member of the BioMed Central and the American Journal of Respiratory and Critical Care Medicine advisory boards. She is also a member of the editorial boards of a number of international journals. Until 2012, she was Guidelines Director for the European Respiratory Society (ERS) and is currently the Publications Committee Chair of ERS Publications. Eur Respir Monogr 2013 59: vii–viii. Copyright ERS 2013. DOI: 10.1183/1025448x.10000913 Print ISBN: 978-1-84984-032-3 Online ISBN: 978-1-84984-033-0 Print ISSN: 1025-448x Online ISSN: 2075-6674 vii
Previous Page Next Page